Humana Inc vs Vanguard Sht-Term Inflation-Protected Sec Idx ETF — how do they compare? Humana Inc trades at $431.03 (market cap $46.49B), while Vanguard Sht-Term Inflation-Protected Sec Idx ETF trades at $48.46 (market cap $73.20B). The key difference: Vanguard Sht-Term Inflation-Protected Sec Idx ETF is the larger of the two by market cap, and Humana Inc pays a 0.91% dividend while Vanguard Sht-Term Inflation-Protected Sec Idx ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 51 Days and Vanguard Sht-Term Inflation-Protected Sec Idx ETF for 91 Days on average.
| HUM | VTIP | |
|---|---|---|
Market Cap | $46.49B | $73.20B |
Volume | 2,567,704 | 2,511,360 |
Sector | Health | — |
52-Week High | $431.03 | $50.46 |
52-Week Low | $163.67 | $48.38 |
Typical Hold Time | 51 Days | 91 Days |
Enterprise Value | $53.84B | — |
Dividend Yield | 0.91% | — |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 2.37% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $457.05 implying 18% upside. Revenue growth is robust, reaching $129.7 billion in 2025, though net income margin has compressed to 0.88%. Recent news includes a Barclays upgrade to a $515 target and upcoming Q3 earnings on November 6, 2026.
The stock offers potential from strong revenue expansion and positive analyst sentiment, but faces risks from margin pressure and regulatory scrutiny. Institutional activity is mixed, with Bank of America adding a position while some funds reduced stakes. The outlook hinges on earnings performance and Medicare Advantage plan changes affecting membership.
VTIP, the Vanguard Short-Term Inflation-Protected Securities ETF, trades at $48.49, up slightly by 0.06% today. The technical outlook is mixed, with a bearish trend from moving averages but bullish signals from oscillators like the RSI. Recent news highlights its role as an inflation hedge amid rising energy prices and Fed policy shifts, with institutional investors increasing positions. Key support sits at $48, with resistance at $49.
The outlook for VTIP is cautiously positive, offering a low-risk inflation hedge with minimal interest-rate sensitivity. Opportunities include protection against persistent inflation and real yield advantages, but risks involve Fed policy uncertainty and potential underperformance if inflation subsides. Investors should weigh its defensive role in a diversified portfolio.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →The index is a market-capitalization-weighted index that includes all inflation-protected public obligations issued by the US Treasury with remaining maturities of less than 5 years. The advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the securities that make up the index, holding each security in approximately the same proportion as its weighting in the index.
Read more on VTIP →